Investors & Media
TherapeuticsMD, Inc. is an innovative healthcare company focused on developing and commercializing products exclusively for women. With its SYMBODA™ technology, TherapeuticsMD is developing advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company’s clinical development pipeline includes multiple hormone therapy products at various stages of clinical development. The company also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaMedMD® and BocaGreenMD® brands. More information is available at the following websites: vitamedmdrx.com and bocagreenmd.com .
TherapeuticsMD Inc at Goldman Sachs 39th Annual Global Healthcare ConferenceThursday Jun 14, 2018 8:40:am PDT
TherapeuticsMD at Jefferies 2018 Healthcare ConferenceWednesday Jun 06, 2018 9:00:am EDT
TherapeuticsMD 2018 Investor and Analyst DayMonday Jun 04, 2018 12:00:pm EDT
TXMD TX-004HR Regulatory UpdateWednesday May 30, 2018 8:00:am EDT
Q1 2018 TherapeuticsMD Inc Earnings Conference CallThursday May 03, 2018 4:30:pm EDT
(Common Stock) Data as of
Copyright Nasdaq. Minimum 15 minutes delayed.